---
title: "McKesson (MCK) Q2 Earnings: What To Expect"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294763251.md"
description: "McKesson (MCK) reports Q2 earnings Wednesday. Last quarter, revenue grew 6% YoY to $96.3B, missing estimates but beating EPS. This quarter, analysts expect 6.5% revenue growth, slowing from last year's 23.4%. Peers Centene and Tenet Healthcare recently beat estimates. McKesson shares are up 6% over the past month, trading below the average analyst price target of $947.13."
datetime: "2026-08-04T03:13:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294763251.md)
  - [en](https://longbridge.com/en/news/294763251.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294763251.md)
generator: "portal-rs"
---

# McKesson (MCK) Q2 Earnings: What To Expect

Healthcare distributor and services company McKesson will be reporting results this Wednesday afternoon. Here’s what to expect.

McKesson missed analysts’ revenue expectations last quarter, reporting revenues of $96.3 billion, up 6% year on year. It was a slower quarter for the company, with a narrow beat of analysts’ EPS estimates.

Is McKesson a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting McKesson’s revenue to grow 6.5% year on year, slowing from the 23.4% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. McKesson has missed Wall Street’s revenue estimates multiple times over the last two years.

Looking at McKesson’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Centene delivered year-on-year revenue growth of 9.9%, beating analysts’ expectations by 13.1%, and Tenet Healthcare reported revenues up 6.8%, topping estimates by 3.9%. Centene traded down 3.5% following the results while Tenet Healthcare was up 17.2%.

Read our full analysis of Centene’s results here and Tenet Healthcare’s results here.

Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices up 1.9% on average over the last month. McKesson is up 6% during the same time and is heading into earnings with an average analyst price target of $947.13 (compared to the current share price of $831.50).

**ALSO WORTH WATCHING: Nvidia’s Quiet Partner.** Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar.

### Related Stocks

- [MCK.US](https://longbridge.com/en/quote/MCK.US.md)
- [THC.US](https://longbridge.com/en/quote/THC.US.md)
- [CNC.US](https://longbridge.com/en/quote/CNC.US.md)
- [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md)
- [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md)

## Related News & Research

- [D L Carlson Investment Group Inc. Purchases New Shares in McKesson Corporation $MCK](https://longbridge.com/en/news/296587606.md)
- [TFR Capital LLC. Invests $2.49 Million in McKesson Corporation $MCK](https://longbridge.com/en/news/296021268.md)
- [Performance Wealth Partners LLC Acquires Shares of 1,441 McKesson Corporation $MCK](https://longbridge.com/en/news/296210904.md)
- [GSA Capital Partners LLP Purchases New Holdings in McKesson Corporation $MCK](https://longbridge.com/en/news/296193587.md)
- [Danica Pension Livsforsikringsaktieselskab Makes New $48.77 Million Investment in McKesson Corporation $MCK](https://longbridge.com/en/news/296323235.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**